MARKET

LAB

LAB

STANDARD BIOTOOLS INC
NASDAQ
1.260
+0.020
+1.61%
After Hours: 1.280 +0.02 +1.59% 18:14 02/06 EST
OPEN
1.280
PREV CLOSE
1.240
HIGH
1.295
LOW
1.250
VOLUME
1.10M
TURNOVER
--
52 WEEK HIGH
1.720
52 WEEK LOW
0.9200
MARKET CAP
484.55M
P/E (TTM)
-3.7245
1D
5D
1M
3M
1Y
5Y
1D
Standard BioTools veröffentlicht ergänzte Finanzinformationen nach Verkauf der SomaScan-Sparte
Reuters · 2d ago
Standard BioTools Amends Financials After SomaLogic Sale to Illumina
Reuters · 2d ago
Illumina beats Q4 adjusted EPS estimates
Reuters · 2d ago
Weekly Report: what happened at LAB last week (0126-0130)?
Weekly Report · 5d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Scholar Rock Holding (SRRK) and Standard BioTools (LAB)
TipRanks · 01/30 17:02
Standard BioTools Completes Major Proteomics Business Divestiture
TipRanks · 01/30 14:45
Illumina finishes SomaLogic acquisition
Seeking Alpha · 01/30 14:34
Standard BioTools Completes Sale Of SomaLogic To Illumina For Up To $425M Plus Royalties
Benzinga · 01/30 14:14
More
About LAB
Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.

Webull offers Standard Biotools Inc stock information, including NASDAQ: LAB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LAB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LAB stock methods without spending real money on the virtual paper trading platform.